Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.68 |
| ▸ | RARB | P10826 | 6/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | RARA | P10276 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | MTOR | P42345 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9158283 | 1.00 | HSD11B1 (0.68) | HSD11B1RARBALDH1A1MEN1RARA | |
| Ethyne SCHEMBL28914485 | 0.96 | HSD11B1 (0.64) | HSD11B1RARBALDH1A1MEN1RARA | |
| SCHEMBL1203500 | 0.93 | HSD11B1 (0.69) | HSD11B1RARBALDH1A1MEN1RARA | |
| SCHEMBL28842038 | 0.92 | RARB (0.61) | HSD11B1RARBALDH1A1MEN1RARA | |
| Boric Acid SCHEMBL29240144 | 0.92 | RARB (0.61) | HSD11B1RARBALDH1A1MEN1RARA | |
| Bicarbonate SCHEMBL27623751 | 0.92 | RARB (0.71) | HSD11B1RARBALDH1A1MEN1RARA | |
| SCHEMBL5599589 | 0.91 | HSD11B1 (0.67) | HSD11B1RARBALDH1A1MEN1RARA | |
| SCHEMBL1533772 | 0.91 | HSD11B1 (0.67) | HSD11B1RARBALDH1A1MEN1RARA | |
| SCHEMBL4598933 | 0.91 | HSD11B1 (0.67) | HSD11B1RARBALDH1A1MEN1RARA | |
| SCHEMBL9158137 | 0.91 | HSD11B1 (0.67) | HSD11B1RARBALDH1A1MEN1RARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119684802-A | Nuclear grade high-flame-retardant high-temperature-resistant anti-radiation silicone rubber and preparation method and application thereof | 上海电缆研究所有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-118146510-A | Heat-resistant polyarylether resin, synthesis method and application thereof in coating aspect | 浙江鹏孚隆新材料有限公司 | 2024-06-07 | — | — | CN | claimed |
| WO-2023088095-A1 | 7-FLUORO-5-SUBSTITUTED TRYPTAMINE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF | 宁波大学 | 2023-05-25 | — | — | WO | claimed |
| CN-115784965-A | 7-fluoro-5-substituted tryptamine compound and preparation method and application thereof | 宁波大学 | 2023-03-14 | — | — | CN | claimed |
| CN-113296310-A | Quantum dot light conversion layer and preparation method thereof | 广东普加福光电科技有限公司 | 2021-08-24 | — | — | CN | claimed |
| CN-111215129-A | ReOxMethod for catalytically cracking carbon-carbon bond of lignin by HZSM-5 | 中国科学院大连化学物理研究所 | 2020-06-02 | — | — | CN | claimed |
| CN-106119302-A | A kind of method of micro-organisms biphenyl carboxylic acids | 青岛科技大学 | 2016-11-16 | — | — | CN | claimed |
| CN-101240001-B | 2' -fluoro nucleosides | UNIV EMORY | 2013-10-16 | — | — | CN | claimed |
| US-8377948-B2 | Antitumor agents and methods of their use | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2013-02-19 | — | — | US | claimed |
| CN-102336754-A | Synthetic method of entecavir and intermediate compound thereof | TAIZHOU AOXIANG MEDICAL TECHNOLOGY CO LTD | 2012-02-01 | — | — | CN | claimed |
| US-7829741-B2 | Process for producing α, α-difluoroamine | NATIONAL UNIVERSITY CORPORATION (JP) | 2010-11-09 | — | — | US | claimed |
| US-20090177012-A1 | PROCESS FOR PRODUCING ALPHA, ALPHA-DIFLUOROAMINE | NATIONAL UNIVERSITY CORPORATION, HOKKAIDO UNIVERSITY (JP) | 2009-07-09 | — | — | US | claimed |
| US-20090048265-A1 | NOVEL ANTITUMOR AGENTS AND METHODS OF THEIR USE | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2009-02-19 | — | — | US | claimed |
| EP-1813596-A1 | PROCESS FOR PRODUCING ALPHA, ALPHA- DIFLUOROAMINE | National University Corporation Hokkaido University (JP) | 2007-08-01 | — | — | EP | claimed |
| CN-88103202-A | Vinyl cephalosporin compound that replaces and preparation method thereof and as the application of medicine | — | 1988-12-21 | — | — | CN | claimed |
| JP-56090880-A | — | — | None | — | — | JP | disclosed |
| CN-122055371-A | Faster automated iterative C-C bond formation | 伊利诺伊大学评议会 | 2026-05-15 | — | — | CN | disclosed |
| US-4177156-A | SPECIALTY OILS FOR TRANSFORMERS | RHONE-POULENC INDUSTRIES (FR) | 1979-12-04 | — | — | US | disclosed |
| US-4154697-A | Liquid crystalline hexahydroterphenyl derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1979-05-15 | — | — | US | disclosed |
| US-4119555-A | COOLANTS FOR TRANSFORMERS | RHONE-POULENC INDUSTRIES (FR) | 1978-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090048265-A1 | NOVEL ANTITUMOR AGENTS AND METHODS OF THEIR USE | ADRB1, ADRA2A, ADRA1A | HSD11B1 1528/4885RARB 474/4885ALDH1A1 219/4885 |
| US-20090177012-A1 | PROCESS FOR PRODUCING ALPHA, ALPHA-DIFLUOROAMINE | FUCA1, FUCA2, DBH | HSD11B1 1102/4885RARB 790/4885ALDH1A1 522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.